Premium
Pneumocystis carinii pneumonia: Pitfalls of prophylaxis
Author(s) -
MASSIE RJH,
COOPER PJ,
VAN ASPEREN PP,
McINTYRE P
Publication year - 1998
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1046/j.1440-1754.1998.00261.x
Subject(s) - pneumocystis carinii , medicine , pneumonia , trimethoprim , sulfamethoxazole , intensive care medicine , antibiotics , pneumocystis jirovecii , microbiology and biotechnology , biology
Pneumocystis carinii pneumonia (PCP) occurs commonly in immunocompromised patients. Sulfamethoxazole‐trimethoprim (SMX‐TMP) is effective prophylaxis, although PCP may still occur despite apparently adequate use. We report three cases of PCP which highlight some of the pitfalls of prophylaxis.